CENI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.353
EU - Europa 2.253
AS - Asia 417
AF - Africa 5
SA - Sud America 1
Totale 6.029
Nazione #
US - Stati Uniti d'America 3.346
PL - Polonia 812
IE - Irlanda 376
SE - Svezia 329
IT - Italia 275
HK - Hong Kong 179
DE - Germania 95
UA - Ucraina 94
CN - Cina 90
JO - Giordania 71
FI - Finlandia 61
GB - Regno Unito 59
BE - Belgio 55
CH - Svizzera 41
AT - Austria 32
IN - India 29
SG - Singapore 18
VN - Vietnam 16
TR - Turchia 10
FR - Francia 8
ES - Italia 6
RU - Federazione Russa 6
CA - Canada 5
SC - Seychelles 4
TW - Taiwan 4
NL - Olanda 3
HN - Honduras 2
BR - Brasile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
Totale 6.029
Città #
Warsaw 812
Fairfield 477
Dublin 376
Chandler 343
Woodbridge 262
Ashburn 261
Cambridge 216
Seattle 203
Houston 187
Wilmington 178
Jacksonville 164
Ann Arbor 143
Lawrence 112
Hong Kong 110
Altamura 106
Princeton 82
Boston 64
Buffalo 59
Beijing 55
Brussels 55
Florence 54
Boardman 48
Bern 39
San Diego 30
Medford 29
Shanghai 29
Pune 27
New York 26
Falls Church 23
Bremen 20
Vienna 20
Dong Ket 16
Norwalk 16
Hillsboro 10
Hanover 9
Izmir 9
Fiesole 7
Fontebuona 7
Milan 7
Phoenix 7
Andover 6
Barcelona 6
London 6
Singapore 6
Auburn Hills 5
Los Angeles 5
Corigliano Calabro 4
San Giovanni Valdarno 4
Taichung 4
Dearborn 3
Laurel 3
Ottawa 3
Palermo 3
Perugia 3
Washington 3
Bergamo 2
Castelliri 2
Chengdu 2
Chiswick 2
Düsseldorf 2
Grevenbroich 2
Hangzhou 2
Hounslow 2
La Ceiba 2
Redwood City 2
Scandicci 2
Seelow 2
Toronto 2
Turin 2
Wakefield 2
Wanchai 2
Aci Catena 1
Acton 1
Americana 1
Anaheim 1
Antony 1
Bologna 1
Brno 1
Busto Arsizio 1
Cairo 1
Campi Bisenzio 1
Cedar Knolls 1
Chicago 1
Cornaredo 1
Frankfurt Am Main 1
Incisa 1
Islington 1
Lausanne 1
Leawood 1
Manchester 1
Marano Di Napoli 1
Milazzo 1
Montefalco 1
Monza 1
Moscow 1
Mountain View 1
Naaldwijk 1
Nanjing 1
Naples 1
New Bedfont 1
Totale 4.823
Nome #
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 241
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 226
Magnetic hyperthermia and oxidative damage to dna of human hepatocarcinoma cells 223
8-Oxo-7,8-dihydro-2'-deoxyguanosine and other lesions along the coding strand of the exon 5 of the tumour suppressor gene P53 in a breast cancer case-control study. 213
Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective 208
Nuclear orphan receptor COUP-TF2 induces anoikis resistance, amoeboid migration and metastatic potential in hepatocellular carcinoma (HCC) 143
NUCLEAR ORPHAN RECEPTOR COUP-TF2 INCREASED THE RESISTANCE TO ANIKOISIS AND THE METASTATIC POTENTIAL IN HEPATOCELLULAR CARCINOMA 143
A new regulator of mitochondrial OXPHOS in hepatocytes and HCC cell lines: the AAA plus ATPase RuvBL1 130
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. 120
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells 112
Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells. 108
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 107
Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. 106
Acycloguanosyl 5'-thymidyltriphosphate, a Thymidine Analogue Prodrug Activated by Telomerase, Reduces Pancreatic Tumor Growth in Mice. 102
Alcohol induced hepatic fibrosis: role of acetaldehyde. 100
Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells 96
Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism. 96
Antidiabetic thiazolidinediones inhibit hepatic tumor formation in HBV transgenic mouse model. 92
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro 91
Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation 91
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. 87
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma 85
Neuropeptide-leukocyte interactions: examples of pharmacological modulation 84
Genetics, alcohol, and cirrhosis 84
In vivo effects of rosiglitazone in a human neuroblastoma xenograft 84
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms 83
Hepatocyte-specific deletion of RuvBL1 leads to chronic liver damage and regeneration, enhancing HCC development 83
Aldehyde Dehydrogenase-2 (aldh2) Gene Is Differently Expressed In Human Liver Fat-storing Cells (hfsc) and Liver-tissues 82
The potential of antidiabetic thiazolidinediones for anticancer therapy. 76
Regulation of undulin synthesis and gene expression in human fat-storing cells by acetaldehyde and transfroming grwoth factor-B1 76
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R 74
Important Role of Sirt1 In the Survival and Activation of Hepatic Stellate Cells During Liver Injury 73
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production 71
P0244 : Thieno-triazolodiazepines block hepatocarcinoma progression by HSP-dependent kinoma inhibition 71
Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. 70
Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression 70
Evidence for tachykinin NK-2b-like receptors in guinea-pig alveolar macrophages. 68
Peroxisome proliferator-activated receptor gamma (PPARgamma) transcriptional activity is inhibited by acetaldehyde in human hepatic stellate cells (HSC) 67
Intracellular signaling pathways activated by reactive oxygen species regulate proliferation and collagen synthesis of human hepatic stellate cells 67
PPARgamma activation by antidiabetic thiazolidinediones reduces liver fibrosis and hepatic stellate cells activation in vivo 66
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. 65
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. 65
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. 65
Apolipoprotein AI regulatory protein 1 (ARP-1) coordinates profibrogenic responses during liver fibrosis 64
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma 63
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression 63
Acetaldehyde induced collagen synthesis by inhibition of PPARgamma trascriptional activity via hydrogen peroxide-mediated activation of c-Abl non-receptor tyrosine kinase in human hepatic stellate cells 60
Loss of hepatic RuvBL1 accelerates DEN-induced carcinogenesis due to chronic liver damage and regeneration 59
THU-449-Nuclear orphan receptor COUP-TF2 increases the resistence to anoikis and induces amoeboid movment and metastatic potential in hepatocellular carcinoma 57
Enanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins 55
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells 53
Peroxisome prolferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells 49
Acetaldehyde inhibits peroxisome proliferator-activated receptor gamma (PPARg) transcriptional activity in hepatic stellate cells. A MAPk/pkcdelta-dependent mechanism. 49
A N-TRUNCATED ISOFORM OF THE ORPHAN NUCLEAR RECEPTOR COUP-TFII MODULATES PANCREATIC CANCER PROGRESSION 49
The AAA+ ATPase RuvBL1 localizes to mitochondria and supports HCC cell metabolism. 47
Oxydative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism 44
Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1. 43
A MITOCHONDRIAL ROLE FOR THE CANCER-RELATED AAA plus ATP-ASE RUVBL1 42
Paracrine cross-talk between pancreatic cancer cells and periacinar stellate cells enhanced tumor progression 40
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS 40
Loss of Hepatic RuvBL1 Causes Chronic Liver Damage and Regeneration, Promoting Hepatocellular Carcinoma 40
null 39
Human hepatic stellate cells express class I alcohol dehydrogenase and adlehyde dehydrogenase but not cytochrome P4502E1 38
Tachykinins stimulate Lyso-PAF: acetyl-CoA Acetyltransferase activity in Neutrophils 37
RuvBL1 haploinsufficiency improves mTOR-driven NASH-HCC development in mice 35
Genetic polymorphisms in ethanol metabolizing enzymes do not influence the severity of alcoholic liver disease in Italian patients. 35
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma 35
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model 35
The orphan receptor COUP-TF II (Arp-1) is required for stellate cells activation and is involved in mitogenic responses in activated cells. 34
Reactive oxigen species (ROS) modulate mitogenic and motogenic responses in human hepatic stellate cells 34
Ligation-mediated polymerase chain reaction detection of 8-oxo-7,8-dihydro-2′-deoxyguanosine and 5-hydroxycytosine at the codon 176 of the p53 gene of hepatitis c-associated hepatocellular carcinoma patients 34
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 33
THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION 31
THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOUR FORMATION IN HBV TRANSGENIC MICE BY A PPAR gamma-INDEPENDENT REGULATION OF NUCLEOPHOSMIN 30
Helicobacter pylori infection modulates peroxisome proliferator activated receptor gamma (PPARgamma) expression and transcriptional activity. 29
Peroxisome proliferator-activated receptor Gamma (PPAR Gamma) modulates hepatic stellate cells activation. 28
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 26
Tgf-beta Effects On the Synthesis of Extracellular-matrix Components By Human Fat-storing Cells Are Modulated By Different Matrices 26
Pentoxifylline causes degradation of procollagen I produced by human hepatic stellate cells in response to transforming growth factor-beta 1 24
SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY 24
Oxidative stress induce collagen synthesis by c-Abl activation in human hepatic stellate cells 23
A mitochondrial role of RuvBL1 ATPase in the regulation of HCC cell metabolism 22
RuvBL1 ATPase activity is essential for mitochondrial integrity and function in HCC cells 16
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS 14
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice 13
Telomerase Activated Thymidine Analogue Prod-drug Prevents Growth and Induces Regression In Two In Vivo Models of Hepatocellular Carcinoma 8
Totale 6.084
Categoria #
all - tutte 17.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019433 0 0 0 0 0 0 0 0 20 89 177 147
2019/20201.371 93 107 34 110 163 170 148 176 138 85 122 25
2020/2021818 74 73 79 81 33 101 31 68 67 106 43 62
2021/2022558 22 49 23 33 25 24 23 29 23 26 127 154
2022/20231.691 125 317 76 139 99 279 240 89 210 13 48 56
2023/2024610 43 71 103 36 71 116 33 129 8 0 0 0
Totale 6.084